StockData
Avenue Therapeutics, Inc. logo

Avenue Therapeutics, Inc. (ATXI) stock

ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$0.43+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.42MP/E –Yield –

Avenue Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Avenue Therapeutics's market cap was $1.42M on Oct 16, 2026, against $2.29M a year earlier. Over the last 5 years it ranged from $507.85K to $23.68M, with a median of $2.32M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 16, 2026$1.42M-34.6%
2025Dec 31, 2025$2.17M-32.5%
2024Dec 31, 2024$3.21M+122.3%
2023Dec 29, 2023$1.44M-16.0%
2022Dec 30, 2022$1.72M-88.7%
2021Dec 31, 2021$15.25M-84.7%
2020Dec 31, 2020$99.65M-37.7%
2019Dec 31, 2019$159.95M+177.8%
2018Dec 31, 2018$57.58M+54.9%
2017Dec 29, 2017$37.16M–

More Avenue Therapeutics figures

See a number that looks wrong?